483
LTS Therapy Systems, LLCFDA 483 - LTS Therapy Systems, LLC - January 31, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Tapemark Company, a drug manufacturer in Saint Paul, MN, was cited for significant deficiencies in its quality control unit during an FDA inspection. Observations included failures to adhere to procedures for Corrective and Preventive Actions (CAPA) and Non-Conformance Management (NCM), as well as an inadequate product recall procedure. These issues indicate a lack of adherence to established quality system requirements.
Open in Dashboard
ID · 50020131-5c36-4231-8ee8-f4b12932e89e